The uselfulness of the khorana risk score depending on the type of non-hodgkin&#39;s lymphomas

Buruiana Sanda; Robu Maria; Tomacinschii Victor; Mazur Minodora

Articolul precedent

Articolul urmator

445

Căutarea după subiecte
similare conform CZU

616-005.6/.7:616-006.441 (1)

Patologie. Medicină clinică (6963)

SM ISO690:2012

BURUIANA, Sanda, ROBU, Maria, TOMACINSCHII, Victor, MAZUR, Minodora. The uselfulness of the khorana risk score depending on the type of non-hodgkin's lymphomas. In: Scientific Collection ”InterConf”, 26-28 noiembrie 2020, Washington. Washington, USA : EnDeavours Publisher, 2020, Vol. 3(36), pp. 987-992. ISBN 979-1-293-10109-3.

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

Scientific Collection ”InterConf”
Vol. 3(36), 2020

Conferința "Scientific and Practical Conference «Challenges in Science of Nowadays»"
Washington, Statele Unite ale Americii, 26-28 noiembrie 2020

The uselfulness of the khorana risk score depending on the type of non-hodgkin's lymphomas

CZU: 616-005.6/.7:616-006.441

Pag. 987-992

Buruiana Sanda, Robu Maria, Tomacinschii Victor, Mazur Minodora

”Nicolae Testemițanu” State University of Medicine and Pharmacy

Disponibil în IBN: 4 februarie 2021

Rezumat

Non-Hodgkin's lymphoma (NHL) is one of the most common malignancies [1, 2] with an increased risk of thromboembolism [3]. Knowing the risk factors allows the evaluation of the risk-benefit ratio of thromboprophylaxis [4].

Cuvinte-cheie
Non-Hodgkin lymphoma, score, thrombosis

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-121415</cfResPublId>
<cfResPublDate>2020</cfResPublDate>
<cfVol>Vol. 3(36)</cfVol>
<cfStartPage>987</cfStartPage>
<cfISBN>979-1-293-10109-3</cfISBN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/121415</cfURI>
<cfTitle cfLangCode='EN' cfTrans='o'>The uselfulness of the khorana risk score depending on the type of non-hodgkin&#39;s lymphomas</cfTitle>
<cfKeyw cfLangCode='EN' cfTrans='o'>Non-Hodgkin lymphoma; score; thrombosis</cfKeyw>
<cfAbstr cfLangCode='EN' cfTrans='o'><p>Non-Hodgkin&#39;s lymphoma (NHL) is one of the most common malignancies [1, 2] with an increased risk of thromboembolism [3]. Knowing the risk factors allows the evaluation of the risk-benefit ratio of thromboprophylaxis [4].</p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-17453</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11551</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-60743</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11763</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-17453</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-17453-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
<cfFamilyNames>Buruiana</cfFamilyNames>
<cfFirstNames>Sanda</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11551</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11551-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
<cfFamilyNames>Robu</cfFamilyNames>
<cfFirstNames>Maria</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-60743</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-60743-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
<cfFamilyNames>Tomacinschii</cfFamilyNames>
<cfFirstNames>Victor</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11763</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11763-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
<cfFamilyNames>Mazur</cfFamilyNames>
<cfFirstNames>Minodora</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>